Sidley Austin represented OnCusp Therapeutics, Inc. in the transaction. OnCusp Therapeutics, Inc., a biopharmaceutical company, announced it has raised US$100 million (more than RMB700 million) Series A...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here